Glucose Metabolism in Pregnant Women With a History of Bariatric Surgery, as Well as Three to Six Months After Delivery.
NCT ID: NCT03190148
Last Updated: 2017-06-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
64 participants
INTERVENTIONAL
2014-02-13
2016-05-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Bariatric Surgery and Consequences for Mother and Baby in Pregnancy
NCT03713060
Glucose Homeostasis, Metabolomics and Pregnancy Outcomes After Bariatric Surgery
NCT05084339
Effect of Ghrelin on Glucose Metabolism After Bariatric Surgery
NCT02953587
Effect of Obesity, Diabetes and Bariatric Surgery on Pregnancy Outcomes
NCT05753124
Nutritional Status of prEgnant Women Following BariatrIc surgEry
NCT06796829
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Pregnant women with RYGB-operation
Pregnant women with a history of RYGB-Operation were investigated.
OGTT
A standardized 75g oral Glucose tolerance test was accomplished.
IVGTT
For the exact assessment of Glucose metabolism in the study participants an intravenous Glucose tolerance test (IVGTT) was accomplished
1H-magnetic resonance spectroscopy
For the assessment of the ectopic lipid content in the liver, heart and the muscle a 1H-magnetic resonance spectroscopy was accomplished three to six months after delivery
Normal weight pregnant women
Normal weight pregnant women were investigated.
OGTT
A standardized 75g oral Glucose tolerance test was accomplished.
IVGTT
For the exact assessment of Glucose metabolism in the study participants an intravenous Glucose tolerance test (IVGTT) was accomplished
1H-magnetic resonance spectroscopy
For the assessment of the ectopic lipid content in the liver, heart and the muscle a 1H-magnetic resonance spectroscopy was accomplished three to six months after delivery
Obese Pregnant women
Obese pregnant women were investigated.
OGTT
A standardized 75g oral Glucose tolerance test was accomplished.
IVGTT
For the exact assessment of Glucose metabolism in the study participants an intravenous Glucose tolerance test (IVGTT) was accomplished
1H-magnetic resonance spectroscopy
For the assessment of the ectopic lipid content in the liver, heart and the muscle a 1H-magnetic resonance spectroscopy was accomplished three to six months after delivery
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
OGTT
A standardized 75g oral Glucose tolerance test was accomplished.
IVGTT
For the exact assessment of Glucose metabolism in the study participants an intravenous Glucose tolerance test (IVGTT) was accomplished
1H-magnetic resonance spectroscopy
For the assessment of the ectopic lipid content in the liver, heart and the muscle a 1H-magnetic resonance spectroscopy was accomplished three to six months after delivery
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* normal weight pregnant women
* obese pregnant women
Exclusion Criteria
18 Years
45 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medical University of Vienna
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Alexandra Kautzky-Willer
Univ.Prof.Dr.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Alexandra Kautzky-Willer, Univ.Prof.Dr.
Role: PRINCIPAL_INVESTIGATOR
Department of Internal Medicine III, Clinical Division of Endocrinology and Metabolism, Unit of Gender Medicine, Medical University of Vienna
References
Explore related publications, articles, or registry entries linked to this study.
Leutner M, Klimek P, Gobl C, Bozkurt L, Harreiter J, Husslein P, Eppel W, Baumgartner-Parzer S, Pacini G, Thurner S, Kautzky-Willer A. Glucagon-like peptide 1 (GLP-1) drives postprandial hyperinsulinemic hypoglycemia in pregnant women with a history of Roux-en-Y gastric bypass operation. Metabolism. 2019 Feb;91:10-17. doi: 10.1016/j.metabol.2018.10.006. Epub 2018 Nov 15.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PBS-1090
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.